Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drugs

Showing results (611-620 of 7,076) with videos related to

Pageof 708
Sort By:
Drugs|October 1, 1986
Oxaprozin. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacyP A Todd, R N Brogden
Drugs|January 1, 1986
The diuretic dilemma and the management of mild hypertensionM Moser
Drugs|November 7, 1999
ExemestaneL J Scott, L R Wiseman
Drugs|December 20, 1999
Mechanisms of fluoroquinolone resistance: an update 1994-1998L J Piddock
Drugs|December 20, 1999
Activity of quinolones against mycobacteriaM R Jacobs
Drugs|December 20, 1999
Activity of newer fluoroquinolones in vitro against gram-positive bacteriaG M Eliopoulos
Drugs|December 20, 1999
Pharmacokinetics and pharmacodynamics of fluoroquinolonesJ Turnidge
Drugs|December 20, 1999
Quinolone use in the developing world: state of the artT E Tupasi
Drugs|December 20, 1999
Quinolones in sexually transmitted diseases: state of the artG L Ridgway
Drugs|December 20, 1999
Newer quinolones in the long term prophylaxis of recurrent urinary tract infections (UTI)S Krcméry, J Hromec, M Tvrdikova, et al.
Pageof 708

Showing results (611-620 of 7,076) with videos related to

Sort By:
Pageof 708
Drugs|October 1, 1986
Oxaprozin. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacyP A Todd, R N Brogden
Drugs|January 1, 1986
The diuretic dilemma and the management of mild hypertensionM Moser
Drugs|November 7, 1999
ExemestaneL J Scott, L R Wiseman
Drugs|December 20, 1999
Mechanisms of fluoroquinolone resistance: an update 1994-1998L J Piddock
Drugs|December 20, 1999
Activity of quinolones against mycobacteriaM R Jacobs
Drugs|December 20, 1999
Activity of newer fluoroquinolones in vitro against gram-positive bacteriaG M Eliopoulos
Drugs|December 20, 1999
Pharmacokinetics and pharmacodynamics of fluoroquinolonesJ Turnidge
Drugs|December 20, 1999
Quinolone use in the developing world: state of the artT E Tupasi
Drugs|December 20, 1999
Quinolones in sexually transmitted diseases: state of the artG L Ridgway
Drugs|December 20, 1999
Newer quinolones in the long term prophylaxis of recurrent urinary tract infections (UTI)S Krcméry, J Hromec, M Tvrdikova, et al.
Pageof 708